When I was more youthful, less cynical, and thought that some of the world’s most severe problems could be solved if every American just gave a dime, or a quarter, or a dollar, I had no idea how expensive fixing some of the world’s problems could be. George W.
I am sorry to see that my pal Grant Aldonas has fallen out of the rumour mill on who might be the next U.S. Trade Representative. Chris Nelson of the Nelson Report gives a glimpse of the latest jockeying, both for USTR and the next Director General of the World Trade Organization.
I have posted in the past several items on the question of forced anthrax vaccinations among our military ranks. What I have found interesting in this debate are the lengths that DoD civilian leaders are willing to go to obfuscate for and hide from Congressional oversight what the key intelligence is that justifies these vaccinations….
My friend and colleague Peter Bergen is headed back from Saudi Arabia’s first international terrorism conference in Riyadh. He writes: In the sprawling desert city where Osama bin Laden was born almost half a century ago, last week the Saudis held their first international counterterrorism conference.
Josh Marshall gave me the nudge to start my own blog and then moved off to New York where he has been ferociously battling Bush’s Social Security privatization campaign. But though I talk to Josh a lot, email him, and do a lot of instant messaging, I haven’t actually seen him in a while.
Something is up in Asia. North Korea finally, overtly acknowledges it has nuclear warheads — and Japan announces it wants to cut what it spends supporting U.S. forces on its islands. Japan apparently plans to tell the U.S.
Note to TWN Readers: I’m not a funny guy, and I tell jokes badly.
These almost sound like John Grisham titles — but they are respectively the new London Review of Books article ‘title’ on the future of the Supreme Court I recommended a few days ago — and mention of the author, Bruce Ackerman. It’s a very instructive and important article. Here is the link.
$720 billion for that drug benefit through 2015? The cost was already too high at $400 billion.
